Goodvastatin Gold 10 Capsule is a combination medication containing Aspirin (75 mg), Atorvastatin (10 mg), and Clopidogrel (75 mg), designed for the prevention and management of cardiovascular diseases. Aspirin acts as an antiplatelet agent by irreversibly inhibiting cyclooxygenase-1 (COX-1), thereby reducing thromboxane A2 production and preventing platelet aggregation. Atorvastatin, a potent HMG-CoA reductase inhibitor, effectively lowers low-density lipoprotein cholesterol (LDL-C) and total cholesterol levels, contributing to the reduction of atherosclerotic plaque formation. Clopidogrel, another antiplatelet agent, selectively inhibits the ADP receptor on platelet cell membranes, further preventing platelet activation and aggregation. The synergistic effect of these three agents makes Goodvastatin Gold 10 Capsule suitable for patients at high risk of myocardial infarction, stroke, and other thrombotic events, especially those with established coronary artery disease or peripheral arterial disease. This combination therapy aids in reducing cardiovascular morbidity and mortality by targeting multiple pathways involved in thrombosis and lipid metabolism. It is essential to use this medication under medical supervision, considering potential contraindications such as bleeding disorders, hypersensitivity, or concurrent use of other anticoagulants. Regular monitoring of liver function, lipid profile, and complete blood count is recommended during therapy.